Skip to content Skip to footer

CE Marking For Software As Medical Device (SaMD)

Medical Device Software

SOFTWARE AS A MEDICAL DEVICE (SaMD)

In the ever-evolving landscape of healthcare technology, the designation of Software as a Medical Device (SaMD) plays a pivotal role in ensuring the safety and efficacy of digital solutions designed to impact patient care. The CE marking for SaMD stands as a testament to compliance with European regulations, underscoring a commitment to meeting stringent standards in the development and deployment of software within the medical domain. This distinction is not merely a badge but a symbol of the conscientious effort invested in aligning technological innovation with the highest standards of medical device regulation.

As the healthcare industry undergoes a digital transformation, SaMD emerges as a key player in facilitating diagnostic, therapeutic, and monitoring processes. The regulatory framework encompassing software as a medical device recognizes the unique challenges and opportunities presented by this dynamic field. Navigating through the intricacies of compliance, developers and manufacturers of SaMD aim to create solutions that not only meet regulatory requirements but also contribute significantly to patient outcomes and healthcare efficiency.

What is Software as a Medical Device (SaMD)?

Software as a Medical Device (SaMD) refers to software that is intended to be used for medical purposes on its own, without being part of a hardware medical device. In other words, SaMD is software that functions as a medical device and is designed to perform medical functions without being tied to a specific piece of hardware.

Annex-XVI refers to a category of products that are subject to specific regulations and directives to ensure their safety, quality, and environmental impact. These products cover a wide range of industries, including medical devices, construction products, machinery, electrical equipment, and more. The purpose of Annex-XVI is to safeguard the health and safety of consumers, as well as the environment.

CE marking is a mandatory requirement for Annex-XVI products sold within the European Economic Area (EEA). It indicates that a product has undergone the necessary conformity assessment procedures and meets the essential health, safety, and environmental protection requirements set out by the European Union (EU). CE marking provides assurance to manufacturers, distributors, and end-users that the product is safe and compliant with applicable regulations.

Key characteristics of Software as a Medical Device include:

  1. Independent Functionality: SaMD operates as a standalone software application or program, independent of any particular hardware medical device. It is designed to achieve its intended medical purpose without being an integral part of a physical device.
  2. Medical Purpose: SaMD is intended for use in the diagnosis, prevention, monitoring, treatment, or alleviation of disease or injury. It may also be used for the investigation, replacement, modification, or support of the anatomy or of a physiological process.
  3. Regulatory Oversight: SaMD is subject to regulatory oversight to ensure its safety, effectiveness, and compliance with relevant medical device regulations. In the European Union, SaMD is regulated under the EU Medical Device Regulation (MDR) or In Vitro Diagnostic Device Regulation (IVDR), depending on its classification.
  4. Wide Range of Applications: SaMD encompasses a wide range of applications, including medical imaging software, health information systems, clinical decision support tools, monitoring applications, and other software intended for medical purposes.
  5. Risk Classification: SaMD is classified based on the level of risk it poses to patients and users. The risk classification determines the regulatory requirements and level of scrutiny applied to the software during the conformity assessment process.
  6. Conformity Assessment: Manufacturers of SaMD are required to perform a conformity assessment to demonstrate that the software meets the essential requirements for safety and performance. This includes clinical evaluation and performance evaluation.

Examples of Software as a Medical Device include:

  • Diagnostic software: Software used for the interpretation of medical images or laboratory test results.
  • Clinical decision support systems: Software providing recommendations to healthcare professionals based on patient data.
  • Monitoring and alerting software: Software used for continuous monitoring of physiological parameters and issuing alerts in case of abnormalities.
  • Health information systems: Software managing and processing patient health records for healthcare providers.

CE marking process for Software as a Medical Device (SaMD)

The regulatory framework for SaMD is outlined in the EU Regulation 2017/745 on Medical Devices (Medical Device Regulation or MDR) and the EU Regulation 2017/746 on In Vitro Diagnostic Medical Devices (In Vitro Diagnostic Device Regulation or IVDR)

Here are key points regarding the CE marking for Software as a Medical Device:

1. Classification of SaMD:
  • Determine Classification:SaMD is classified based on its associated risk, and the classification rules are outlined in Annex VIII of the MDR and IVDR.
Class I: Low Risk SaMD

1.Health and Wellness Apps:

  • Mobile applications that provide general health and wellness information, lifestyle advice, and basic tracking functionalities.

2. Appointment Scheduling Software:

Software designed to assist healthcare providers and patients in managing appointment schedules and reminders.

Class IIa: Medium Risk SaMD
  1. Physiological Parameter Monitoring Software:
  • Software that monitors and tracks physiological parameters, such as heart rate, blood pressure, and glucose levels, for non-critical conditions.

2. Medication Management Apps:

  • Applications that help users manage medication schedules, provide dosage reminders, and offer basic information about medications.

3. Clinical Decision Support Software (Limited Scope):

  • Software providing guidance to healthcare professionals based on specific data inputs, but with a moderate level of complexity.
Class IIb: Medium to High Risk SaMD

1. More Complex Clinical Decision Support Software:

  • Software offering advanced clinical decision support for healthcare professionals, covering a broader range of medical conditions and requiring a higher level of complexity.

2. Diagnostic Imaging Software (Non-Critical):

  • Software used for diagnostic imaging purposes, such as non-critical radiological image interpretation.

3. Remote Patient Monitoring Systems:

  • Software systems for monitoring patients with chronic conditions, involving more complex algorithms and risk management.
Class III: High Risk SaMD

1. Critical Diagnostic Decision Support Software:

  • Software providing crucial diagnostic support for life-threatening conditions, requiring a high level of accuracy and reliability.

2. Closed-Loop Control Systems:

  • Software involved in closed-loop control systems for active implantable medical devices, where the software directly influences the device’s function.

3. Life-Supporting Software:

  • Software integrated into life-supporting medical devices, such as ventilators or infusion pumps, where the correct functioning of the software is critical for patient safety.
2. Conformity Assessment:
  • Conduct Conformity Assessment: The manufacturer must carry out a conformity assessment to demonstrate that the SaMD complies with the relevant essential requirements of the MDR or IVDR.
  • Quality Management System (QMS): Manufacturers are required to have a quality management system in place, and compliance with ISO 13485:2016 is generally accepted as evidence of conformity.
3. Clinical Evaluation and Performance Evaluation:
  • Clinical Evaluation: For higher-risk SaMD, a clinical evaluation must be conducted to assess the safety and performance of the software. Clinical evaluation is the systematic and ongoing process of collecting, appraising, and analyzing clinical data pertaining to a SaMD to verify its safety, performance, and clinical benefits.
  • Performance Evaluation: The manufacturer must perform a performance evaluation for SaMD to demonstrate its effectiveness and intended purpose. Performance evaluation involves assessing the analytical and clinical performance of the SaMD, including its accuracy, reliability, and ability to provide the intended results.
4. Technical Documentation:
  • Prepare Technical Documentation: Manufacturers must create and maintain technical documentation that provides evidence of conformity with the General Safety Performance Requirements (GSPR).
5. Post-Market Surveillance:
  • Implement Post-Market Surveillance (PMS): Establish processes for monitoring the performance of SaMD once it is on the market. This includes collecting and analyzing data on the SaMD’s safety and performance.
6. EU Declaration of Conformity:
  • Issue EU Declaration of Conformity: The manufacturer or their authorized representative must issue a Declaration of Conformity stating that the SaMD complies with the relevant requirements.
7. Notified Body Involvement (if applicable):
  • Determine Notified Body Involvement: Not all SaMD require the involvement of a Notified Body. However, for certain classes, a Notified Body may need to be involved in the conformity assessment process.
8. CE Marking:
  • Affix the CE Mark: If the conformity assessment is successful, affix the CE marking to the SaMD. The CE marking indicates compliance with the applicable regulatory requirements.

Comparison of SaMDs and Medical device software

Sr. No. Software as a Medical Device (SaMD) Medical Device Software
1 SaMD refers to software that is intended to be used for medical purposes without being part of a hardware medical device. It is a category of software that functions as a medical device on its own. "Medical device software" is a broader term that encompasses any software that is part of or integral to a medical device. It includes software components embedded within or associated with a hardware medical device.
2 Independence: SaMD operates independently and is not an integral part of a physical medical device. It can be a standalone software application or program designed to perform medical functions. Medical device software is not standalone; it is integrated into or associated with a physical medical device. This could include software embedded in a medical device or software used to control or monitor the functions of a hardware device.
3 Regulatory Framework: SaMD is subject to specific regulatory frameworks, such as the European Union Medical Device Regulation (EU MDR) or the U.S. Food and Drug Administration (FDA) regulations, which provide guidelines for the development, marketing, and use of medical devices. Regulatory Framework: The regulatory requirements for medical device software depend on its role and classification as part of the overall medical device. The entire medical device, including its software components, is subject to regulatory scrutiny.
4 Risk Classification: SaMD is classified based on the level of risk it poses to patients and users. The classification determines the regulatory requirements and level of scrutiny applied during conformity assessment. Risk Classification: The risk classification of medical device software is determined as part of the overall classification of the medical device to which it belongs.
5 Examples: Clinical decision support software, diagnostic imaging software, mobile health applications, and monitoring software are examples of SaMD. Examples: Software embedded in an infusion pump, control software for an implantable medical device, and software used in a diagnostic imaging system are examples of medical device software.

In the United States, where the demand for innovative healthcare technologies is ever-growing, the prominence of SaMD is gaining momentum. The robust regulatory landscape of the USA necessitates a thorough understanding of the classification and approval processes governing software as a medical device. Developers and stakeholders engaged in the SaMD sector in the USA recognize the importance of adherence to regulatory standards to gain market access and foster trust among healthcare practitioners and end-users.

The software as a medical device landscape is marked by continuous evolution and adaptation to emerging technologies. The CE marking for SaMD serves as a beacon, guiding developers through the intricate maze of compliance, quality assurance, and risk management. It is a testament to the commitment to delivering solutions that not only meet regulatory benchmarks but also contribute meaningfully to the advancement of patient care. As the USA continues to embrace the potential of SaMD, the significance of adhering to established regulatory norms becomes even more pronounced, ensuring that innovation in healthcare technology aligns seamlessly with the overarching goal of improving patient outcomes and healthcare delivery.

HOW MAVEN CAN HELP WITH MDR SOFTWARE CE MARKING?

Specialized Expertise in SaMD Compliance:
    • Maven stands out by providing specialized expertise in the compliance requirements for Software as Medical Device. This ensures a meticulous approach tailored to the unique challenges presented by SaMD.
Strategic Alignment with Regulations:
    • Maven understands the intricacies of the regulatory landscape, aligning its approach with the specific requirements of the country. This targeted focus ensures that the MDR software achieves seamless compliance with the EU standards.
Streamlined Regulatory Documentation:
    • Maven streamlines the often complex process of preparing regulatory documentation. By leveraging its expertise in software as a medical device, Maven ensures that the CE marking journey is marked by clarity, accuracy, and efficiency.
Proactive Approach to Regulatory Changes:
    • Recognizing the dynamic nature of regulatory landscapes, Maven adopts a proactive stance in anticipating and adapting to changes. This ensures that the SaMD remains compliant with both existing and emerging regulations in the USA, safeguarding its market presence.